semaglutide patent expiry in india With patents expiring India, domestic drugmakers like Dr. Reddy's, Glenmark, Natco, and Alkem are launching affordable versions of Ozempic and Wegovy. Prices have dropped from Rs 11,000 to as low Indian Pharma Billionaires Pile Into
Description
Westwood, MA
Semaglutide is a popular weight loss drug that also treats diabetes, but new research shows a troubling trend
Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss by Bartelt et al.
Safe & Affordable weight loss
California lawmakers are moving to cut Medicaid coverage for some expensive weight-loss drugs, such as Novo Nordisks Wegovy and Eli Lillys Zepbound, in a bid to reduce the states $12 billion budget deficit.
